The HOOK2 Knockout HAP1 Polyclonal Cells represent a genetically engineered pooled cell population derived from the HAP1 human haploid fibroblast-like cell line, in which the HOOK2 gene has been disrupted using CRISPR/Cas9-mediated gene targeting. Unlike clonal isolates, this polyclonal format preserves population-level heterogeneity while providing a functional knockout background for loss-of-function studies. This product is designed to facilitate investigations into HOOK2-dependent cellular processes without assumptions of monoclonality or homozygous knockout status, making it ideally suited for pooled screening approaches and comparative phenotypic analyses where clonal variation is not desired.
The parental HAP1 cell line is a near-haploid, adherent cell model originally derived from the KBM-7 chronic myeloid leukemia line. Its haploid karyotype greatly simplifies genetic manipulation and phenotype interpretation, as single allele disruption ablates gene function entirely. This attribute, combined with robust growth characteristics and ease of transfection, has established HAP1 as a workhorse in forward genetic screens and CRISPR-based knockout generation. The HAP1 background supports diverse biochemical and imaging assays, and its fibroblast-like morphology is compatible with studies of organelle dynamics, centrosome biology, and cell migration.
HOOK2 encodes a coiled-coil protein that acts as a molecular linker between organelles and the microtubule network, with established roles in centrosome cohesion, primary cilium assembly, and aggresome formation. Mechanistically, HOOK2 activity is modulated by AKT-mediated phosphorylation, which regulates its affinity for microtubules and centrosomal accumulation. At this organelle, HOOK2 cooperates with HOOK1, HOOK3, and PCM1 to organize pericentriolar material and recruit CEP135, influencing dynein-dynactin-dependent transport. It also facilitates trafficking of IFT components such as IFT88 and couples endosomal trafficking to aggresome clearance through interactions with Rab5 and the dynein-dynactin complex. Thus, HOOK2 integrates AKT signals to orchestrate microtubule-based organelle positioning and homeostasis.
Introduction of HOOK2 loss-of-function in the HAP1 haploid landscape creates a powerful model for deciphering centrosome biology and autophagy pathways without compensatory wild-type alleles. Researchers can employ this polyclonal knockout population to dissect the molecular requirements for centrosome cohesion, a process frequently dysregulated in cancer cells exhibiting centrosome amplification, or to study ciliogenesis defects relevant to ciliopathies and Hedgehog signaling. Because the cells retain their near-haploid state, the phenotype is directly attributable to HOOK2 disruption, facilitating unambiguous assignment of roles to downstream effectors such as PCM1 and CEP135.
Typical experimental applications include quantitative assessment of ciliogenesis using serum-starvation protocols and immunofluorescence, centrosome cohesion assays via ??-tubulin staining, and aggresome formation assays using proteasome inhibitors. Western blotting and RT-qPCR enable validation of HOOK2 depletion and monitoring of pathway components like AKT, IFT88, or Rab8. Co-immunoprecipitation can be used to probe disrupted HOOK2?CPCM1 or HOOK2?Cdynein interactions, while migration assays assess functional consequences on cell motility. For further information on batch-specific performance or to discuss custom applications, please contact Ascent Research.
